Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Mackenzie Paul, a 25-year-old medical student from Sault Ste. Marie, has been documenting her battle with Acute Myeloid ...
A UN report reveals that only a small proportion of secondary cancers in survivors are related to radiation therapy.
Interviewing the neuroscientist and primate behavior expert on a question that could radically change our understanding of ...
A phase 2 clinical study (NCT03974022)found that sunvozertinib (Zegfrovy) was efficacious in 2 different doses, but ...
The strange thing about having terminal cancer at 37 is that, in some ways, I’m much happier than I had been before my ...
Gone are the days when breast cancer screening meant discomfort, radiation, and anxiety. This Breast Cancer Awareness Month, ...
Australians with the extremely rare and life-threatening inherited disease, acid sphingomyelinase deficiency (ASMD) will now have free access to a ...
Parkinson’s disease, once considered relatively rare, is now one of the most common neurological disorders in the world, and ...
As a young breast cancer survivor myself, I think the best awareness comes from survivors sharing our stories. I also really ...
In EGFR-mutated advanced NSCLC, first line osimertinib plus platinum-pemetrexed prolonged overall survival versus monotherapy ...
17hon MSN
Study unveils mechanisms driving axonal accumulation of TDP-43 and associated nerve damage in ALS
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results